Bg pattern

GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

GLUTAFERRO170 mg/ml oral drops in solution

(Ferroglycine sulfate)

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet:

  1. What is Glutaferro and what is it used for
  2. What you need to know before you take Glutaferro
  3. How to take Glutaferro
  4. Possible side effects
  5. Storage of Glutaferro
  6. Contents of the pack and further information

1. What is Glutaferro and what is it used for

Glutaferro is presented as oral drops in solution.

This medicinal product belongs to the group of medicinal products called iron supplements.

Glutaferro is used for the treatment of iron deficiency conditions.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Glutaferro

Do not take Glutaferro

  • If you are allergic to ferroglycine sulfate or any of the other ingredients of this medicinal product (listed in section 6).
  • If you have esophageal stenosis (narrowing) due to any type of gastrointestinal disorder.
  • If you have iron overload (increased amount of iron in the blood).

Warnings and precautions

Consult your doctor, pharmacist, or nurse before taking this medicinal product.

Iron preparations can cause poisoning, especially in children.

This medicinal product should be administered with caution.

  • If you are taking another iron supplement in your diet and/or iron salts.
  • If you have any of these diseases: hemolytic anemia, hemoglobinopathies (blood diseases that alter oxygen transport), myelodysplasia (inadequate functioning of the bone marrow) or alterations in iron absorption or storage.

Other medicines and Glutaferro

Use of Glutaferro with other medicines. Inform your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

The effect of treatment may be affected if Glutaferro is administered simultaneously with other medicines.

Intravenous administration of iron salts and doxycycline should be avoided.

Glutaferro should not be administered until at least two to four hours after the administration of any of the following therapeutic agents:

  • Antacids: the therapeutic effect of Glutaferro may be impaired if administered concomitantly with antacids. The minimum time interval between the administration of antacids and iron is two hours.
  • Thyroid hormones: Glutaferro decreases the effect of medicines containing thyroid hormones if administered concomitantly. The minimum time interval between the administration of thyroid hormones and iron is two hours.
  • Anti-infectious medicines: Glutaferro decreases the effect of certain anti-infectious medicines (tetracyclines and fluoroquinolones) if administered simultaneously. In the case of fluoroquinolones, they should be administered at least two hours before or four hours after Glutaferro. In the case of tetracyclines other than doxycycline, the interval between administration should be at least three hours.
  • Other medicines: other medicines may be affected by treatment with Glutaferro: methyldopa (administer with the widest possible interval), penicillamine (administer at least two hours before Glutaferro), bisphosphonates (administer with an interval of at least two hours), levodopa (administer with the widest possible interval), or non-steroidal anti-inflammatory drugs (may increase the irritating effect on the gastric mucosa of these drugs).

Use of Glutaferro with food, beverages, and alcohol

It is advisable to take the medicine at least 2 hours away from meals, as absorption may be reduced. Do not take the medicine with food, vegetable foods, milk or derivatives, coffee, tea, or beverages containing calcium. Iron absorption is decreased with calcium and with other agents present in certain foods that form complexes with iron.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.

No known risks have been described with iron intake during pregnancy and breastfeeding.

Driving and using machines

No effects of this medicine on the ability to drive or use machines have been observed.

Glutaferro contains sorbitol.

This medicinal product contains 300 mg of sorbitol per ml.

Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medicine.

Glutaferro contains sodium

This medicinal product contains less than 23 mg of sodium (1 mmol) per daily dose, which is essentially "sodium-free".

3. How to take Glutaferro

Follow exactly the administration instructions of this medicinal product given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

Iron salts should be taken between meals for maximum absorption. If gastrointestinal side effects are observed, they should be administered during or after meals. In the case of children, Glutaferro can be administered mixed with water, juices, and even milk.

The recommended dose in adults is 1.5-2.5 ml three times a day.

Use in children and adolescents:

Up to 1 year and premature: ………….. 0.3-0.5 ml per day distributed with food.

From 1 to 6 years: …………………………. 0.2-0.7 ml three times a day.

Over 6 years: ………………….. 0.7 ml three times a day.

Treatment should continue until normal iron values are reached in the blood or until body iron reserves are restored.

If you experience side effects, consult your doctor. If you think the action of Glutaferro is too strong or too weak, tell your doctor or pharmacist.

If you take more Glutaferro than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service. Telephone 91 562.04.20 indicating the medicine and the amount ingested. Bring the package leaflet with you.

If you forget to take Glutaferro

Do not take a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

During the administration of Glutaferro, the following adverse reactions may occur:

Abdominal discomfort, heartburn, vomiting, diarrhea, constipation, dark stools, and exanthema (temporary skin rash).

These adverse reactions appear very rarely (affect less than 1 in 10,000 people).

Reporting of side effects

If you experience side effects, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Glutaferro

Keep this medicinal product out of the sight and reach of children.

This medicinal product does not require any special storage temperature.

Expiry date:

Do not use this medicinal product after the expiry date stated on the packaging after - EXP. The expiry date is the last day of the month indicated.

Do not use this medicinal product if you notice that the packaging or closure is damaged.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and medicines you no longer need in the pharmacy's SIGRE point. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and further information

Composition of Glutaferro

The active substance of this medicinal product is ferroglycine sulfate 170 mg equivalent to 30 mg of Iron(II).

The other ingredients (excipients) are: sorbitol (E-420), sodium saccharin, orange essence, caramel. See section 2.

Appearance of the product and pack contents

Glutaferro is presented as oral drops in solution in packs containing 25 ml of solution and a dosing dropper.

Marketing authorization holder

MEDIX, S.A.

Calle del Plástico, nº 5 nave 9

Polígono Industrial Miralcampo

19200 Azuqueca de Henares (Guadalajara)

Manufacturer

INDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A.

C/La Laguna 66-68-70, Polígono Industrial Urtinsa II Alcorcón, 28923 (Madrid)

This leaflet was last revised in 07/2021

Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/

Online doctors for GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS

Discuss questions about GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS?
GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS?
The active ingredient in GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS is ferrous glycine sulfate. This information helps identify medicines with the same composition but different brand names.
Who manufactures GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS?
GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS is manufactured by Medix S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS?
Other medicines with the same active substance (ferrous glycine sulfate) include FERBISOL 100 mg GASTRO-RESISTANT CAPSULES, FERRO SANOL 100 mg GASTRO-RESISTANT CAPSULES, FERO-GRADUMET 105 mg PROLONGED-RELEASE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media